About Implansense
Built by people who've sat in the EP clinic
Implansense was founded from direct observation of what device clinic teams deal with every day — not from a product roadmap built around what we assumed they needed.
The problem nobody was solving
Tobias Rosen founded Implansense after spending time embedded with device clinic teams at several Philadelphia-area hospitals. What he observed wasn't a technology gap — it was a workflow gap.
The remote monitoring infrastructure was working exactly as designed. Devices were transmitting. Data was arriving at the clinic. But the clinic's workflow to receive, review, and act on that data hadn't kept pace with the volume of devices under management.
The result: a nurse manager sitting in front of 200 transmissions at 8:00 AM with no structured way to identify which four of those 200 needed a phone call that morning — and which 196 could be triaged tomorrow.
The problem wasn't that devices weren't sending data. It was that all the data looked equally urgent by the time it hit the clinic queue. Manufacturer monitoring platforms are optimized for data completeness, not clinical prioritization. That's the gap Implansense fills.
The platform's three-module structure — Alert Triage Engine, Remote Follow-Up Scheduler, Clinical Timeline — maps directly to the three distinct workflow bottlenecks observed across device clinic operations: sorting transmissions, scheduling follow-ups, and understanding patient context during review.
Our mission: ensure no clinically significant cardiac event goes unaddressed because it was buried in a transmission queue.
Built in a city with one of the strongest medtech ecosystems in the US
Philadelphia is home to Penn Medicine, Jefferson Health, Temple University Health System, and Children's Hospital of Philadelphia — one of the highest concentrations of academic cardiology programs and EP practices on the East Coast. Building Implansense here means direct access to the clinical environment the platform serves.
The Philadelphia medtech and life sciences community — anchored by the Science Center, PIDC-supported biotech programs, and the University City Innovation District — provides a strong foundation for building clinical software with rigorous product standards.
$3.5M seed round, 2024
Implansense raised a $3.5M seed round to accelerate platform development and expand integrations with cardiac remote monitoring services. The round reflects a clear need: EP clinics need better tools to manage the volume of remote monitoring data their patients generate.
Seed funding is being deployed to complete SOC 2 Type II certification, expand the integration surface area, and build out the clinical advisory program with device clinic teams.
Read the announcementMeet the team or see the platform
Connect with Implansense to discuss your clinic's workflow or learn more about what we're building.